159 related articles for article (PubMed ID: 10342749)
21. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
[TBL] [Abstract][Full Text] [Related]
22. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.
Travers JB; Hamid QA; Norris DA; Kuhn C; Giorno RC; Schlievert PM; Farmer ER; Leung DY
J Clin Invest; 1999 Nov; 104(9):1181-9. PubMed ID: 10545517
[TBL] [Abstract][Full Text] [Related]
23. Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis.
de la Torre B; Fransson J; Scheynius A
Clin Exp Rheumatol; 1995; 13(3):345-8. PubMed ID: 7554562
[TBL] [Abstract][Full Text] [Related]
24. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
25. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
Kiss M; Husz S; Molnár K; Dobozy A
Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
[TBL] [Abstract][Full Text] [Related]
26. [Disorders of interleukin cascade reactions in pemphigus and pemphigoid and methods for their correction].
Grando SA
Vestn Dermatol Venerol; 1989; (9):10-3. PubMed ID: 2692341
[TBL] [Abstract][Full Text] [Related]
27. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
[TBL] [Abstract][Full Text] [Related]
28. Binding of bullous pemphigoid and pemphigus vulgaris sera to SCaBER cell line in an ELISA.
Cook AL; Mallett RB; Hanahoe TH; Pye RJ
Br J Dermatol; 1989 Jan; 120(1):59-69. PubMed ID: 2700665
[TBL] [Abstract][Full Text] [Related]
29. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of antibody to 230 kDa bullous pemphigoid antigen in lichen planus-like keratosis.
Seishima M; Izumi T; Kanoh H; Kitajima Y
Eur J Dermatol; 1999; 9(5):393-6. PubMed ID: 10417446
[TBL] [Abstract][Full Text] [Related]
31. [Possible effect of interleukin-17 blockade in pemphigus foliaceus and neutrophilic diseases].
Kohlmann J; Simon JC; Kunz M; Treudler R
Hautarzt; 2019 Aug; 70(8):641-644. PubMed ID: 31076811
[TBL] [Abstract][Full Text] [Related]
32. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
Jordon RE; Kawana S; Fritz KA
J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
[TBL] [Abstract][Full Text] [Related]
33. Expression of pemphigoid antigen by SV40-transformed human keratinocytes.
Okada N; Kitano Y; Miyagawa S; Sakamoto K; Steinberg ML
J Invest Dermatol; 1986 Apr; 86(4):399-401. PubMed ID: 2427614
[TBL] [Abstract][Full Text] [Related]
34. Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases.
Economidou J; Avgerinou G; Tsiroyianni A; Stavropoulos P; Vareltzidis A; Katsambas A
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):184-5. PubMed ID: 9784051
[No Abstract] [Full Text] [Related]
35. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
36. The caspase-1 inhibitor CARD18 is specifically expressed during late differentiation of keratinocytes and its expression is lost in lichen planus.
Qin H; Jin J; Fischer H; Mildner M; Gschwandtner M; Mlitz V; Eckhart L; Tschachler E
J Dermatol Sci; 2017 Aug; 87(2):176-182. PubMed ID: 28506683
[TBL] [Abstract][Full Text] [Related]
37. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line.
Seishima M; Esaki C; Osada K; Mori S; Hashimoto T; Kitajima Y
J Invest Dermatol; 1995 Jan; 104(1):33-7. PubMed ID: 7798638
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
Hammers CM; Stanley JR
Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
40. Lichenoid erythrodermic bullous pemphigoid of the African patient.
Joly P; Tanasescu S; Wolkenstein P; Bocquet H; Gilbert D; Thomine E; Wechsler J; Roujeau JC; Revuz J; Tron F; Lauret P
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):691-7. PubMed ID: 9810884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
